Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.33%57.236.5%$169.22m
CTLTCatalent, Inc. -1.45%78.002.4%$132.70m
VRXValeant Pharmaceuticals International, Inc. 0.29%17.2014.1%$101.21m
JAZZJazz Pharmaceuticals Plc 1.08%106.602.4%$81.66m
UTHRUnited Therapeutics Corp. 0.45%117.4414.3%$68.96m
BHCBausch Health Cos., Inc. 0.29%17.200.0%$68.81m
ICPTIntercept Pharmaceuticals, Inc. 2.80%45.0916.8%$63.68m
PCRXPacira Biosciences, Inc. 0.49%57.8010.3%$55.61m
AXSMAxsome Therapeutics, Inc. 1.37%83.041.9%$51.78m
ZGNXZogenix, Inc. -2.05%27.247.5%$47.44m
PRGOPerrigo Co. Plc 1.68%55.176.8%$45.82m
MYOKMyoKardia, Inc. -0.29%92.861.8%$45.18m
ARGXargenx SE -1.04%250.510.0%$42.94m
GWPHGW Pharmaceuticals Plc -0.16%127.906.2%$38.07m
ICLRICON plc -2.48%169.964.3%$37.43m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.